The role of intensive care nurses in cellular treatments during the COVID-19 pandemic

Basit Öğe Kaydı
dc.authoridÇALIŞKAN, FİGEN/0000-0002-5086-3571
dc.authorid, rabia/0000-0003-1707-4607
dc.authorwosidÇALIŞKAN, FİGEN/AHD-5623-2022
dc.contributor.authorCaliskan, Figen
dc.contributor.authorOzdemir, Irem Nur
dc.contributor.authorZeydan, Ayten
dc.contributor.authorKandemir, Canan
dc.contributor.authorYilmaz, Rabia
dc.contributor.authorKaraoz, Erdal
dc.contributor.authorAdas, Gokhan Tolga
dc.date.accessioned2024-05-19T14:40:30Z
dc.date.available2024-05-19T14:40:30Z
dc.date.issued2024
dc.departmentİstinye Üniversitesien_US
dc.description.abstractBackground: Today, the use of cellular therapies as an effective treatment in the field of health is increasing. In the COVID-19 pandemic or similar situations, cellular therapies may be sometimes life-saving. The COVID-19 pandemic has shown us that the training of intensive care nurses in special cases, such as cellular therapies, is insufficient.Aim: The study aimed to determine the duties, responsibilities and training of intensive care nurses on mesenchymal stem cells (MSCs) transplantation to critically ill patients during the COVID-19 pandemic.Study Design: This descriptive and retrospective study was conducted on 107 critically ill patients diagnosed with COVID-19 infection and followed up in the intensive care unit (ICU) between April 2020 and April 2022. Each patient was transplanted MSCs by intravenous infusion three times. Before starting cellular therapy applications, intensive care nurses were selected to work on this treatment modality. Each nurse was given theoretical and practical training by experienced instructors.Results: Intensive care nurses trained for MSCs transplants took part in the pre-application, preparation, application and post-application period. MSCs were checked by the ICU nurses in the pre-application period. Patients' vital signs, existing catheters, consciousness status and parameters were checked by nurses in the preparation and application period. No side effects and complications were observed in patients during MSCs transplantation and within the first 24 h. Patients' late complications and mortality were recorded by nurses during the post-application periods.Conclusions: We recommend that nurses working especially in Level 3 ICUs receive training and certification in cellular therapies, especially in hospitals where advanced/cellular treatments are applied.en_US
dc.description.sponsorshipWe thanks to the institution for permission to use data related to the study.en_US
dc.description.sponsorshipWe thanks to the institution for permission to use data related to the study.en_US
dc.identifier.doi10.1111/nicc.12989
dc.identifier.endpage64en_US
dc.identifier.issn1362-1017
dc.identifier.issn1478-5153
dc.identifier.issue1en_US
dc.identifier.pmid37905845en_US
dc.identifier.scopus2-s2.0-85175537657en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage58en_US
dc.identifier.urihttps://doi.org10.1111/nicc.12989
dc.identifier.urihttps://hdl.handle.net/20.500.12713/4970
dc.identifier.volume29en_US
dc.identifier.wosWOS:001093408100001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofNursing In Critical Careen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240519_kaen_US
dc.subjectCovid-19 Pandemicen_US
dc.subjectMscs Transplantationen_US
dc.subjectNursing Role In Icuen_US
dc.titleThe role of intensive care nurses in cellular treatments during the COVID-19 pandemicen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu